4.5 Review

New routes in frontotemporal dementia drug discovery

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

Tau PET imaging: present and future directions

Laure Saint-Aubert et al.

MOLECULAR NEURODEGENERATION (2017)

Article Cell Biology

Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis

Tania F. Gendron et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Neurosciences

Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies

Einar M. Sigurdsson

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Biochemistry & Molecular Biology

TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion

Qin Xia et al.

EMBO JOURNAL (2016)

Article Biochemistry & Molecular Biology

UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome

Roland Hjerpe et al.

Review Biochemistry & Molecular Biology

Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies

Ian R. A. Mackenzie et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Multidisciplinary Sciences

Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts

Nicholas J. Kramer et al.

SCIENCE (2016)

Article Neurosciences

C9orf72's Interaction with Rab GTPases-Modulation of Membrane Traffic and Autophagy

Bor L. Tang

FRONTIERS IN CELLULAR NEUROSCIENCE (2016)

Article Multidisciplinary Sciences

ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function

Aarti Sharma et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

Kelly L. Williams et al.

NATURE COMMUNICATIONS (2016)

Review Biotechnology & Applied Microbiology

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

Francesco Panza et al.

BIOMED RESEARCH INTERNATIONAL (2016)

Article Clinical Neurology

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

Lieke H. Meeter et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)

Review Neurosciences

From animal models to human disease: a genetic approach for personalized medicine in ALS

Vincent Picher-Martel et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)

Review Neurosciences

Pathogenesis of FUS-associated ALS and FTD: insights from rodent models

Matthew Nolan et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins

S. Prpar Mihevc et al.

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Sang-Won Min et al.

NATURE MEDICINE (2015)

Article Biotechnology & Applied Microbiology

Targeted Excision of VCP R155H Mutation by Cre-LoxP Technology as a Promising Therapeutic Strategy for Valosin-Containing Protein Disease

Angele Nalbandian et al.

HUMAN GENE THERAPY METHODS (2015)

Article Neurosciences

Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau

Katja Hochgraefe et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events

Meredith E. Jackrel et al.

Article Biochemistry & Molecular Biology

C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking

Manal A. Farg et al.

HUMAN MOLECULAR GENETICS (2014)

Review Neurosciences

Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases

Giulietta Riboldi et al.

MOLECULAR NEUROBIOLOGY (2014)

Article Clinical Neurology

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

Eduardo Tolosa et al.

MOVEMENT DISORDERS (2014)

Article Biochemistry & Molecular Biology

Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models

Sami J. Barmada et al.

NATURE CHEMICAL BIOLOGY (2014)

Review Clinical Neurology

The role of FUS gene variants in neurodegenerative diseases

Hao Deng et al.

NATURE REVIEWS NEUROLOGY (2014)

Article Medicine, Research & Experimental

Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies

Reeteka Sud et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2014)

Article Clinical Neurology

Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

Ian R. Mackenzie et al.

ACTA NEUROPATHOLOGICA (2013)

Review Genetics & Heredity

Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials

Dian K. Nurputra et al.

ANNALS OF HUMAN GENETICS (2013)

Review Biochemistry & Molecular Biology

Repeat-associated non-ATG (RAN) translation in neurological disease

John D. Cleary et al.

HUMAN MOLECULAR GENETICS (2013)

Article Biochemistry & Molecular Biology

Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation

Alex Crowe et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Review Clinical Neurology

Tau pathology and neurodegeneration

Maria Grazia Spillantini et al.

LANCET NEUROLOGY (2013)

Review Clinical Neurology

Criteria for the diagnosis of corticobasal degeneration

Melissa J. Armstrong et al.

NEUROLOGY (2013)

Article Multidisciplinary Sciences

Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

Clotilde Lagier-Tourenne et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Cell Biology

Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

Dhruv Sareen et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Clinical Neurology

Frontotemporal Dementia

David C. Perry et al.

SEMINARS IN NEUROLOGY (2013)

Article Neurosciences

Reducing TDP-43 aggregation does not prevent its cytotoxicity

Rui Liu et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)

Article Psychiatry

The epidemiology of frontotemporal dementia

Chiadi U. Onyike et al.

INTERNATIONAL REVIEW OF PSYCHIATRY (2013)

Article Biochemistry & Molecular Biology

Spt4 Is Selectively Required for Transcription of Extended Trinucleotide Repeats

Chia-Rung Liu et al.

Article Biochemistry & Molecular Biology

Cellular Model of TAR DNA-binding Protein 43 (TDP-43) Aggregation Based on Its C-terminal Gln/Asn-rich Region

Mauricio Budini et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biotechnology & Applied Microbiology

Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference

Troels Tolstrup Nielsen et al.

JOURNAL OF GENE MEDICINE (2012)

Article Geriatrics & Gerontology

FUS and TDP43 genetic variability in FTD and CBS

Edward D. Huey et al.

NEUROBIOLOGY OF AGING (2012)

Article Geriatrics & Gerontology

Accumulation of insoluble forms of FUS protein correlates with toxicity in Drosophila

Laetitia Miguel et al.

NEUROBIOLOGY OF AGING (2012)

Review Biochemistry & Molecular Biology

TDP-43: gumming up neurons through protein-protein and protein-RNA interactions

Emanuele Buratti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2012)

Review Neurosciences

ALS and Frontotemporal Dysfunction: A Review

Eugene Y. Achi et al.

NEUROLOGY RESEARCH INTERNATIONAL (2012)

Article Clinical Neurology

Frontotemporal Dementia Caused by CHMP2B Mutations

A. M. Isaacs et al.

Current Alzheimer Research (2011)

Article Clinical Neurology

FTD and ALS: A Tale of Two Diseases

R. Ferrari et al.

CURRENT ALZHEIMER RESEARCH (2011)

Article Clinical Neurology

Phenotypic signatures of genetic frontotemporal dementia

Jonathan D. Rohrer et al.

CURRENT OPINION IN NEUROLOGY (2011)

Article Biochemistry & Molecular Biology

TDP-43 regulates its mRNA levels through a negative feedback loop

Youhna M. Ayala et al.

EMBO JOURNAL (2011)

Review Neurosciences

Biomarkers in frontotemporal lobar degenerations-Progress and challenges

William T. Hu et al.

PROGRESS IN NEUROBIOLOGY (2011)

Article Clinical Neurology

Tau in Alzheimer Disease and Related Tauopathies

K. Iqbal et al.

CURRENT ALZHEIMER RESEARCH (2010)

Article Neurosciences

Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model

Allal Boutajangout et al.

JOURNAL OF NEUROSCIENCE (2010)

Review Clinical Neurology

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia

Ian R. A. Mackenzie et al.

LANCET NEUROLOGY (2010)

Article Multidisciplinary Sciences

Enhancement of proteasome activity by a small-molecule inhibitor of USP14

Byung-Hoon Lee et al.

NATURE (2010)

Article Clinical Neurology

A new subtype of frontotemporal lobar degeneration with FUS pathology

Manuela Neumann et al.

Article Biochemistry & Molecular Biology

VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death

Michael A. Gitcho et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia

Rosa Rademakers et al.

HUMAN MOLECULAR GENETICS (2008)

Review Neurosciences

Tau exon 10 alternative splicing and tauopathies

Fei Liu et al.

MOLECULAR NEURODEGENERATION (2008)

Article Neurosciences

Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43

Yong-Jie Zhang et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Biochemistry & Molecular Biology

Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration

Jennifer Gass et al.

HUMAN MOLECULAR GENETICS (2006)

Article Multidisciplinary Sciences

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Manuela Neumann et al.

SCIENCE (2006)

Article Clinical Neurology

Genetic variability in CHMP2B and frontotemporal dementia

Parastoo Momeni et al.

NEURODEGENERATIVE DISEASES (2006)

Review Biochemistry & Molecular Biology

Mutations causing neurodegenerative tauopathies

M Goedert et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)

Review Biochemistry & Molecular Biology

Pathways of tau fibrillization

J Kuret et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)

Article Biochemistry & Molecular Biology

Promotion of hyperphosphorylation by frontotemporal dementia tau mutations

AD Alonso et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Correction of disease-associated exon skipping by synthetic exon-specific activators

L Cartegni et al.

NATURE STRUCTURAL BIOLOGY (2003)

Article Biochemistry & Molecular Biology

AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation

E Rabinovich et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)

Review Biochemistry & Molecular Biology

microRNAs: Tiny regulators with great potential

V Ambros

Article Biochemistry & Molecular Biology

Correction of alternative splicing of tau in frontotemporal dementia and Parkinsonism linked to chromosome 17

B Kalbfuss et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Multidisciplinary Sciences

Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

RB DeMattos et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments

AD Alonso et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Neurosciences

Neurodegenerative tauopathies

VMY Lee et al.

ANNUAL REVIEW OF NEUROSCIENCE (2001)